Clinical Trial Update: Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysis [Phase 3]

View source ↗

Summary

This Phase 3 trial compares MCI-196 to simvastatin for dyslipidemia in patients with chronic kidney disease on dialysis, with results posted after completion in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Dyslipidemia

Drugs mentioned

• MCI-196
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2014-10-17